SNP rsl98389 (T-381 C) polymorphism in the B-type natriuretic peptide gene promoter in patients with atherosclerotic renovascular hypertension

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 4, 2009, Pages 219-224

  Porȩba, Rafalł ^a   Pocza̧tek, Karol ^a   Gać, Pawelł ^a   Porȩba, Malłgorzata ^a   Gonerska, Marzena ^a   Jonkisz, Anna ^a   Derkacz, Arkadiusz ^a   Negrusz Kawecka, Marta ^a   Sobieszczańska, Malłgorzata ^a   Pilecki, Witold ^a   Szuba, Andrzej ^a   Andrzejak, Ryszard ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Atherosclerosis; B type natriuretic peptide (bnp) precursor gene promoter; Polymorphism; Renal artery stenosis (ras); Renovascular hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENOMIC DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ALLELE; ARTERIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; KIDNEY ARTERY STENOSIS; LEUKOCYTE; MALE; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; RENOVASCULAR HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; ANGIOGRAPHY; BLOOD; GENETICS; MIDDLE AGED;

ANGIOGRAPHY; ATHEROSCLEROSIS; FEMALE; GENOTYPE; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL ARTERY OBSTRUCTION;

EID: 67149143351     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bokhari SW, Faxon DP. Current advances in the diagnosis and treatment of renal artery stenosis. Rev Cardiovasc Med. 2004; 5: 204-215.
2. Libertino JA, Bosco PJ, Ying CY, et al. Renal revascularization to preserve and restore renal function. J Urol. 1992; 147:1485-1487.
3. Senitko M, Fenves AZ. An update on renovascular hypertension. Curr Cardiol Rep. 2005; 7:405-411.
4. Textor SC. Atherosclerotic renal artery stenosis: how big is the problem, and what happens if nothing is done? J Hypertens. 2005; Suppl 3: S5-S13.
5. Working Group of Polish Society of Hypertension. [Guidelines for the diagnosis and management of arterial hypertension caused by renal artery stenosis (renovascular hypertension)]. Nadciśn Tȩtn. 2006; 10: 489-500. Polish.
6. Andrzejak R. [Determinants of therapeutical success of percutaneous transluminal renal angioplasty in patients with hypertension caused by atherosclerotic renal artery stenosis). Pol Arch Med Wewn. 2006; 115: 99-104. Polish.
7. Januszewicz A, Cybulska I, Janaszek-Sitkowska H, et al. [Renovascular hypertension-clinical presentation, diagnosis and pharmacological treatment). In: Januszewicz A, Szmida J, Wiecek A, eds. [Hypertension of renal origin). Kraków, Medycyna Praktyczna, 2003:145-152. Polish.
8. Scarpioni R, Michieletti E, Cristinelli L, et al. Atherosclerotic renovascular disease: Medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression. The rationale and study design of a prospective, mufticenter and randomized trial (NITER). J Nephrol. 2005; 18: 423-428.
9. Fernando D, Garasic J. Percutaneous intervention for renovascular disease: rationale and patient selection. Curr Opin Cardiol. 2004; 19:582-588.
10. Lekston A, Chudek J, Gasior M, et al. Angiographic and intravascular ultrasound assessment of immediate and 9-month efficacy of percutaneous transluminal renal artery balloon angioplasty with subsequent brachytherapy in patients with renovascular hypertension. Kidney Blood Press Res. 2008; 31:291-298.
11. Silva JA, Chan AW, White CJ, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005; 111:328-333.
12. Mussalo H, Vanninen E, Ikaheimo R, et al. NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney Blood Press Res. 2003; 26:34-41.
13. Lanfear DE, Stolker JM, Marsh S, et al. Genetic variation in the B-type natiuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther. 2007; 21:55-62.
14. Lajer M, Tarnow L, Jorsal A, et al. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients. Nephrol Dial Transplant. 2007; 22: 3235-3239.